Trade trend analysis
Number of Transactions
Quantity
Weight
Number of Transactions
Quantity
Weight
The above chart presents the market trend analysis for cdymax india pharma pvt ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 109 transactions, with a transaction quantity of 16451.31 and a transaction weight of 200.
-
2025
503
152333.34
15333.89
-
2026
109
16451.31
200
Bill of lading data
<
1/15
>
-
Trade date
2026/06/22
B/L No.
108364343360
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
công ty cổ phần dược phẩm savi
-
POLs
——
PODs
——
-
Supply area
India
Purchas area
Vietnam
-
Weight
——
Amount
78000
-
Hs code
29335990
Product tags
piperazine,pyrimidine
-
Product description
Nguyên Liệu Hóa Dược làm thuốc:Tenofovir Disoproxil Fumarate,TCNSX (In-House),BN:TDFB26028, TDFB26029, TDFB26030, TDFB26031, TDFB26032,SDK:VD-33533-19, NSX:05/2026 HD:04/2031.
Expand
-
Trade date
2026/06/11
B/L No.
108329743100
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
công ty cổ phần dược vật tư y tế hải dương
-
POLs
——
PODs
——
-
Supply area
India
Purchas area
Vietnam
-
Weight
——
Amount
1500
-
Hs code
29335990
Product tags
piperazine,pyrimidine
-
Product description
Tenofovir alafenamide fumarate .Nguyên liệu để làm mẫu kiểm nghiệm, nghiên cứu thuốc. Lô số: TAFB25004P1.NSX: 12/2025. HSD:11/2030. NSX: CDYMAX (INDIA) PHARMA PRIVATE LIMITED. Mới100%
Expand
-
Trade date
2026/06/10
B/L No.
108326253230
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
chi nhánh công ty tnhh glandcore
-
POLs
——
PODs
——
-
Supply area
India
Purchas area
Vietnam
-
Weight
——
Amount
33216.6
-
Hs code
29335990
Product tags
piperazine,pyrimidine
-
Product description
Nguyên liệu sx thuốc-dược chất:Tenofovir disoproxil fumarate.TCCL:In house. Số lô: TDFB025059 (NSX:06/2025.HSD:05/2030), TDFB025068 (NSX:06/2025.HSD:05/2030), CB:893110113224. Mới 100%
Expand
-
Trade date
2026/06/08
B/L No.
108318066363
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
công ty cp dược minh hải
-
POLs
——
PODs
——
-
Supply area
India
Purchas area
Vietnam
-
Weight
——
Amount
67500
-
Hs code
29349990
Product tags
heterocyclic compounds,methylthio
-
Product description
Nguyên liệu Dược sản xuất thuốc: GEFITINIB, Tiêu chuẩn:In-house/IP2021, Lô: GFTF26002P1, NSX: T02/2026 - HD: T01/2031, NSX: CDYMAX (INDIA) PHARMA PRIVATE LIMITED
Expand
-
Trade date
2026/05/19
B/L No.
——
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
oncogen pharma
-
POLs
——
PODs
kpaf
-
Supply area
India
Purchas area
Pakistan
-
Weight
——
Amount
48605.486535
-
Hs code
29359090
Product tags
pazopanib hydrochloride,pharmaceutical raw material
-
Product description
PHARMACEUTICAL RAW MATERIAL PAZOPANIB HYDROCHLORIDE
Expand
-
Trade date
2026/05/18
B/L No.
108249523061
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
công ty cp dược minh hải
-
POLs
——
PODs
——
-
Supply area
India
Purchas area
Vietnam
-
Weight
——
Amount
37500
-
Hs code
29349990
Product tags
heterocyclic compounds,methylthio
-
Product description
Nguyên liệu Dược sản xuất thuốc: CAPECITABINE, Tiêu chuẩn: USP 44, Lô: CPTB25062P1, NSX: T04/2025 - HD: T03/2028, NSX: CDYMAX (INDIA) PHARMA PRIVATE LIMITED
Expand
-
Trade date
2026/04/13
B/L No.
108146751421
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
công ty cp dược minh hải
-
POLs
——
PODs
——
-
Supply area
India
Purchas area
Vietnam
-
Weight
——
Amount
71250
-
Hs code
29335990
Product tags
piperazine,pyrimidine
-
Product description
Nguyên liệu Dược sản xuất thuốc: IMATINIB MESYLATE, Tiêu chuẩn: In-house, Lô: IMAI26003P2, NSX: T02/2026, HSD: T01/2031, NSX: CDYMAX (INDIA) PHARMA PRIVATE LIMITED
Expand
-
Trade date
2026/04/09
B/L No.
108133722541
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
công ty trách nhiệm hữu hạn sinh dược phẩm hera
-
POLs
——
PODs
——
-
Supply area
India
Purchas area
Vietnam
-
Weight
——
Amount
20000
-
Hs code
29337900
Product tags
lactams,caprolactam
-
Product description
Sunitinib Malate, nguyên liệu độc là dược chất,BTP để sản xuất thuốc,dạng bột,có STT 91 trong DM1 TT 09/2024/TT-BYT. Batch No. SNMB24003, NSX:05/2024, HSD:04/2029, mới100%
Expand
-
Trade date
2026/04/02
B/L No.
108113128910
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
chi nhánh công ty tnhh glandcore
-
POLs
——
PODs
——
-
Supply area
India
Purchas area
Vietnam
-
Weight
——
Amount
41010.3
-
Hs code
29335990
Product tags
piperazine,pyrimidine
-
Product description
Nguyên liệu SX thuốc tân dược :Dược chất Tenofovir Disoproxil Fumarate;TCCL:NSX;Batch:TDFB25224 & TDFB25225,SX:09/2025,HD:08/2030;Công bố:893110465623
Expand
-
Trade date
2026/02/28
B/L No.
6252443
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
ms.remedica ltd.
-
POLs
bangalore
PODs
larnaca
-
Supply area
India
Purchas area
Cyprus
-
Weight
——
Amount
75929.46
-
Hs code
29349990
Product tags
ale,batch number,alectinib,hydrochloride
-
Product description
ALECTINIB HYDROCHLORIDE BATCH NUMBER ALEA25002
Expand
-
Trade date
2026/02/27
B/L No.
1284367
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
m2 logistik
-
POLs
bangalore
PODs
münden
-
Supply area
India
Purchas area
Germany
-
Weight
——
Amount
322619.6
-
Hs code
29335990
Product tags
imatinib mesylate,bat
-
Product description
IMATINIB MESYLATE BATCH NO IMAI24008
Expand
-
Trade date
2026/02/25
B/L No.
107999864340
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
công ty cp dược minh hải
-
POLs
——
PODs
——
-
Supply area
India
Purchas area
Vietnam
-
Weight
——
Amount
37500
-
Hs code
29349990
Product tags
heterocyclic compounds,methylthio
-
Product description
Nguyên liệu Dược sản xuất thuốc: CAPECITABINE, Tiêu chuẩn: USP 44, Lô: CPTB25001BP1, NSX: T08/2024 - HD: T07/2027, NSX: CDYMAX (INDIA) PHARMA PRIVATE LIMITED
Expand
-
Trade date
2026/02/24
B/L No.
8226454
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
hikma pharma s.a.
-
POLs
bangalore
PODs
cairo
-
Supply area
India
Purchas area
Egypt
-
Weight
——
Amount
11678137
-
Hs code
29335990
Product tags
bat,p1,itb,ibrutinib
-
Product description
IBRUTINIB BATCH NO ITBA022001P1
Expand
-
Trade date
2026/02/18
B/L No.
1542117
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
bioprofarma bago s.a.
-
POLs
bangalore
PODs
buenos aires
-
Supply area
India
Purchas area
Argentina
-
Weight
——
Amount
2233451.62
-
Hs code
29349990
Product tags
capecitabine,bat
-
Product description
CAPECITABINE USP BATCH NO CPTB25098
Expand
-
Trade date
2026/02/17
B/L No.
3825656
-
Suppliers
cdymax india pharma pvt ltd.
Buyers
.world medicine ilac san.ve.t
-
POLs
bangalore
PODs
istanbul
-
Supply area
India
Purchas area
Turkey
-
Weight
——
Amount
36193095.87
-
Hs code
29335990
Product tags
bcf,bat,palbociclib
-
Product description
PALBOCICLIB BATCH NO PBCF25001 PBCF25002& PBCF25003
Expand
+View All
Products
Total 167
-
bat
530
82.04%
>
-
f1
152
23.53%
>
-
tenofovir disoproxil fumarate
71
10.99%
>
-
p1
65
10.06%
>
-
palbociclib
60
9.29%
>
+View All
Hscode rank
Total 39
-
HS 29335990
354
54.8%
>
-
HS 29349990
98
15.17%
>
-
HS 29339990
66
10.22%
>
-
HS 29359090
39
6.04%
>
-
HS 30049099
20
3.1%
>
+View All
cdymax india pharma pvt ltd. is india Buyer&Supplier,
and primarily engages in the import and export business of products such as bat,f1,tenofovir disoproxil fumarate.
According to the 52wmb.com global trade database, as of 2026-06-22, the company has completed 1613 international trades,
The core products include HS29335990,HS29349990,HS29339990 etc,
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on cdymax india pharma pvt ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.